John W. Chidsey - 15 Apr 2024 Form 4 Insider Report for Encompass Health Corp (EHC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Apr 2024, 16:36:21 UTC
Prior SEC filing
18 Jan 2024
Next SEC filing
07 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Patrick Darby, attorney-in-fact for John W. Chidsey

Key filing fact

John W. Chidsey filed Form 4 for Encompass Health Corp (EHC) on 16 Apr 2024.

Key facts

  • This page summarizes John W. Chidsey's Form 4 filing for Encompass Health Corp (EHC).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Apr 2024, 16:36.

Change

  • Previous filing in this sequence was filed on 18 Jan 2024.
  • Current net transaction value: +$18,608.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EHC transaction

Encompass Health Common Stock

Award

Transaction value
$0
Shares
+176
Change %
+0.11%
Price
$0.000000
Shares after
162,592
Date
15 Apr 2024
Ownership
Direct
Footnotes
F1
EHC transaction

Encompass Health Common Stock

Award

Transaction value
$18,608
Shares
+234
Change %
+0.14%
Price
$79.52
Shares after
162,826
Date
16 Apr 2024
Ownership
Direct
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $80.73. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Footnote F2

The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2023 to defer fixed percentages of their director fees for 2024. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly fee deferral and the dividend of $0.15 per share paid on April 15, 2024.

Footnote F3

This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $79.43 to $79.62, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .